Connor, Clark & Lunn Investment Management (CC&L)’s Prelude Therapeutics PRLD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-17,293
Closed -$35.8K 1596
2024
Q3
$35.8K Buy
17,293
+4,948
+40% +$10.2K ﹤0.01% 1391
2024
Q2
$47K Sell
12,345
-7,721
-38% -$29.4K ﹤0.01% 1330
2024
Q1
$95.1K Buy
+20,066
New +$95.1K ﹤0.01% 1468